vs
Side-by-side financial comparison of CuriosityStream Inc. (CURI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $18.3M, roughly 1.0× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -19.7%, a 16.7% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -25.6%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $2.2M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -10.1%).
Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CURI vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $18.3M |
| Net Profit | $-3.8M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | -17.6% | -2.2% |
| Net Margin | -19.7% | -3.0% |
| Revenue YoY | 35.8% | -25.6% |
| Net Profit YoY | -34.6% | 26.7% |
| EPS (diluted) | $-0.07 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $18.3M | ||
| Q3 25 | $18.4M | $15.9M | ||
| Q2 25 | $19.0M | $16.1M | ||
| Q1 25 | $15.1M | $18.9M | ||
| Q4 24 | $14.1M | $24.7M | ||
| Q3 24 | $12.6M | $28.3M | ||
| Q2 24 | $12.4M | $25.8M | ||
| Q1 24 | $12.0M | $22.7M |
| Q4 25 | $-3.8M | $-554.0K | ||
| Q3 25 | $-3.7M | $-1.8M | ||
| Q2 25 | $784.0K | $-1.5M | ||
| Q1 25 | $319.0K | $-1.5M | ||
| Q4 24 | $-2.8M | $-756.0K | ||
| Q3 24 | $-3.1M | $1.7M | ||
| Q2 24 | $-2.0M | $343.0K | ||
| Q1 24 | $-5.0M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | -17.6% | -2.2% | ||
| Q3 25 | -24.5% | -9.9% | ||
| Q2 25 | 2.5% | -8.4% | ||
| Q1 25 | 0.5% | -7.2% | ||
| Q4 24 | -27.4% | -2.1% | ||
| Q3 24 | -25.8% | 6.8% | ||
| Q2 24 | -20.6% | 2.0% | ||
| Q1 24 | -30.4% | -5.8% |
| Q4 25 | -19.7% | -3.0% | ||
| Q3 25 | -20.4% | -11.0% | ||
| Q2 25 | 4.1% | -9.3% | ||
| Q1 25 | 2.1% | -8.0% | ||
| Q4 24 | -19.9% | -3.1% | ||
| Q3 24 | -24.3% | 5.9% | ||
| Q2 24 | -16.4% | 1.3% | ||
| Q1 24 | -42.0% | -7.6% |
| Q4 25 | $-0.07 | $-0.01 | ||
| Q3 25 | $-0.06 | $-0.05 | ||
| Q2 25 | $0.01 | $-0.05 | ||
| Q1 25 | $0.01 | $-0.04 | ||
| Q4 24 | $-0.05 | $-0.02 | ||
| Q3 24 | $-0.06 | $0.04 | ||
| Q2 24 | $-0.04 | $0.01 | ||
| Q1 24 | $-0.09 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.3M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $41.5M | $37.0M |
| Total Assets | $75.7M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | $10.7M | ||
| Q3 25 | $27.8M | $13.6M | ||
| Q2 25 | $28.1M | $12.5M | ||
| Q1 25 | $33.4M | $11.4M | ||
| Q4 24 | $32.1M | $15.7M | ||
| Q3 24 | $33.2M | $12.3M | ||
| Q2 24 | $39.5M | $11.9M | ||
| Q1 24 | $38.8M | $6.6M |
| Q4 25 | $41.5M | $37.0M | ||
| Q3 25 | $47.2M | $37.0M | ||
| Q2 25 | $49.8M | $30.4M | ||
| Q1 25 | $58.1M | $31.5M | ||
| Q4 24 | $57.8M | $32.6M | ||
| Q3 24 | $62.2M | $29.1M | ||
| Q2 24 | $64.8M | $23.5M | ||
| Q1 24 | $67.0M | $20.6M |
| Q4 25 | $75.7M | $57.1M | ||
| Q3 25 | $74.7M | $57.5M | ||
| Q2 25 | $78.7M | $52.6M | ||
| Q1 25 | $85.3M | $54.0M | ||
| Q4 24 | $86.2M | $59.2M | ||
| Q3 24 | $87.6M | $57.1M | ||
| Q2 24 | $90.9M | $53.0M | ||
| Q1 24 | $94.6M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $2.3M |
| Free Cash FlowOCF − Capex | $3.9M | $2.2M |
| FCF MarginFCF / Revenue | 20.5% | 12.0% |
| Capex IntensityCapex / Revenue | 0.1% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | $2.3M | ||
| Q3 25 | $4.4M | $-1.3M | ||
| Q2 25 | $2.8M | $1.8M | ||
| Q1 25 | $1.9M | $-3.5M | ||
| Q4 24 | $3.0M | $865.0K | ||
| Q3 24 | $2.3M | $4.3M | ||
| Q2 24 | $2.2M | $1.4M | ||
| Q1 24 | $666.0K | $-2.4M |
| Q4 25 | $3.9M | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | $1.8M | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | 20.5% | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | 12.2% | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.5% | 0.3% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.0% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CURI
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
